Suppr超能文献

社区获得性肺炎患者的预后与转归:一项荟萃分析

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.

作者信息

Fine M J, Smith M A, Carson C A, Mutha S S, Sankey S S, Weissfeld L A, Kapoor W N

机构信息

Department of Medicine, University of Pittsburgh, Pa., USA.

出版信息

JAMA. 1996 Jan 10;275(2):134-41.

PMID:8531309
Abstract

OBJECTIVE

To systematically review the medical literature on the prognosis and outcomes of patients with community-acquired pneumonia (CAP).

DATA SOURCES

A MEDLINE literature search of English-language articles involving human subjects and manual reviews of article bibliographies were used to identify studies of prognosis in CAP.

STUDY SELECTION

Review of 4573 citations revealed 122 articles (127 unique study cohorts) that reported medical outcomes in adults with CAP.

DATA EXTRACTION

Qualitative assessments of studies' patient populations, designs, and patient outcomes were performed. Summary univariate odds ratios (ORs) and rate differences (RDs) and their associated 95% confidence intervals (CIs) were computed to estimate a summary effect size for the association of prognostic factors and mortality.

DATA SYNTHESIS

The overall mortality for the 33,148 patients in all 127 study cohorts was 13.7%, ranging from 5.1% for the 2097 hospitalized and ambulatory patients (in six study cohorts) to 36.5% for the 788 intensive care unit patients (in 13 cohorts). Mortality varied by pneumonia etiology, ranging from less than 2% to greater than 30%. Eleven prognostic factors were significantly associated with mortality using both summary ORs and RDs: male sex (OR = 1.3; 95% CI, 1.2 to 1.4), pleuritic chest pain (OR = 0.5; 95% CI, 0.3 to 0.8), hypothermia (OR = 5.0; 95% CI, 2.4 to 10.4), systolic hypotension (OR = 4.8; 95% CI, 2.8 to 8.3), tachypnea (OR = 2.9; 95% CI, 1.7 to 4.9), diabetes mellitus (OR = 1.3; 95% CI, 1.1 to 1.5), neoplastic disease (OR = 2.8; 95% CI, 2.4 to 3.1), neurologic disease (OR = 4.6; 95% CI, 2.3 to 8.9), bacteremia (OR = 2.8; 95% CI, 2.3 to 3.6), leukopenia (OR = 2.5, 95% CI, 1.6 to 3.7), and multilobar radiographic pulmonary infiltrate (OR = 3.1; 95% CI, 1.9 to 5.1). Assessments of other clinically relevant medical outcomes such as morbid complications (41 cohorts), symptoms resolution (seven cohorts), return to work or usual activities (five cohorts), or functional status (one cohort) were infrequently performed.

CONCLUSIONS

Mortality for patients hospitalized with CAP was high and was associated with characteristics of the study cohort, pneumonia etiology, and a variety of prognostic factors. Generalization of these findings to all patients with CAP should be made with caution because of insufficient published information on medical outcomes other than mortality in ambulatory patients.

摘要

目的

系统回顾关于社区获得性肺炎(CAP)患者预后及结局的医学文献。

资料来源

通过对MEDLINE中涉及人类受试者的英文文章进行文献检索,并对文章参考文献进行人工查阅,以确定CAP预后的研究。

研究选择

对4573条引文进行回顾,发现122篇文章(127个独立研究队列)报告了成人CAP的医学结局。

资料提取

对研究的患者群体、设计和患者结局进行定性评估。计算汇总单因素比值比(OR)和率差(RD)及其相关的95%置信区间(CI),以估计预后因素与死亡率关联的汇总效应量。

资料综合

127个研究队列中的33148例患者的总体死亡率为13.7%,范围从6个研究队列中2097例住院及门诊患者的5.1%到13个队列中788例重症监护病房患者的36.5%。死亡率因肺炎病因而异,范围从不到2%到超过30%。使用汇总OR和RD均显示,11个预后因素与死亡率显著相关:男性(OR = 1.3;95%CI,1.2至1.4)、胸膜炎性胸痛(OR = 0.5;95%CI,0.3至0.8)、体温过低(OR = 5.0;95%CI,2.4至10.4)、收缩期低血压(OR = 4.8;95%CI,2.8至8.3)、呼吸急促(OR = 2.9;95%CI,1.7至4.9)、糖尿病(OR = 1.3;95%CI,1.1至1.5)、肿瘤性疾病(OR = 2.8;9%CI,2.4至3.1)、神经系统疾病(OR = 4.6;95%CI,2.3至8.9)、菌血症(OR = 2.8;95%CI,2.3至3.6)、白细胞减少(OR = 2.5,95%CI,1.6至3.7)以及多叶肺部影像学浸润(OR = 3.1;95%CI,1.9至5.1)。对其他临床相关医学结局的评估,如发病并发症(41个队列)、症状缓解(7个队列)、恢复工作或日常活动(5个队列)或功能状态(1个队列)较少进行。

结论

因门诊患者除死亡率外的医学结局的已发表信息不足,将这些结果推广至所有CAP患者时应谨慎。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验